“Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study” (2018) SKIN The Journal of Cutaneous Medicine, 2, p. S64. doi:10.25251/skin.2.supp.64.